Clinical and pathologic features of hepatitis B virus reinfection after liver transplantation
Jeng, L.B.; Ho, Y.C.; Lee, W.C.; Wang, C.C.; Wang, K.L.; Chen, S.C.; Chen, M.F.; Lin, D.Y.; Liaw, Y.F.; Tan, P.P.
Transplantation Proceedings 26(4): 2263-2264
1994
ISSN/ISBN: 0041-1345 PMID: 8066744 Document Number: 426604
Document emailed within 1 workday
Related Documents
Wu, L.-M.; Xu, X.; Zheng, S.-S. 2005: Hepatitis B virus reinfection after liver transplantation: related risk factors and perspective Hepatobiliary and Pancreatic Diseases International: Hbpd Int 4(4): 502-508Niederau, C. 1997: Preventive lamivudine against reinfection by hepatitis B after liver transplantation Zeitschrift für Gastroenterologie 35(5): 359-361
Ikeda, K. 1995: Clinical features of hepatitis C virus-related liver cancer Nihon Rinsho. Japanese Journal of Clinical Medicine 53 Suppl (Part 1): 764-769
Cavallari, A.; Vivarelli, M.; D'Errico, A.; Bellusci, R.; Scarani, P.; De Raffele, E.; Nardo, B.; Gozzetti, G. 1994: Acute necrotizing pancreatitis due to hepatitis B virus reinfection in a liver transplant recipient Transplantation Proceedings 26(6): 3649-3650
Lai, K.N.; Lai, F.M.; Chan, K.W.; Chow, C.B.; Tong, K.L.; Vallance-Owen, J. 1987: The clinico-pathologic features of hepatitis B virus-associated glomerulonephritis Quarterly Journal of Medicine 63(240): 323-333
Wong, P.Y.; McPeake, J.R.; Portmann, B.; Tan, K.C.; Naoumov, N.V.; Williams, R. 1995: Clinical course and survival after liver transplantation for hepatitis B virus infection complicated by hepatocellular carcinoma American Journal of Gastroenterology 90(1): 29-34
Kao, J.H.; Lai, M.Y.; Chen, P.J.; Chen, D.S. 2001: Probable reinfection with hepatitis C virus in a chronic hepatitis C patient with a sustained response to combination therapy Journal of the Formosan Medical Association 100(12): 824-828
Kaneko, J.; Sugawara, Y.; Akamatsu, N.; Kokudo, N.; Makuuchi, M. 2004: Cholestatic hepatitis due to hepatitis C virus after a living donor liver transplantation Hepato-Gastroenterology 51(55): 243-244
Gane, E.J.; Maertens, G.; Ducatteeuw, A.; Qian, K.P.; Lau, J.Y.; Jones, H.; Davies, E.; Naoumov, N.V.; Williams, R. 1999: Antibodies to hepatitis C virus envelope proteins correlate with hepatitis C viraemia after liver transplantation Transplantation 67(1): 78-84
Dumortier, J.ér.ôm.; Chiarello, P.; Adham, M.; Delafosse, B.; Chayvialle, J.-A.; Scoazec, J.-Y.; Boillot, O. 2002: Specific risks of liver transplantation in patients co-infected with hepatitis C virus and human immunodeficiency virus Gastroenterologie Clinique et Biologique 26(11): 1061-1062
Stahel, E.; Tanner, M.; Gyr, N.; Weiss, N.; Hess, C.; Betschart, B. 1984: Seroepidemiology of hepatitis B virus in rural Tanzania: relation of hepatitis B markers and liver function tests in patients with clinical liver disease and in healthy controls East African Medical Journal 61(11): 806-811
Arnold, J.C.; O'Grady, J.G.; Otto, G.; Kommerell, B.; Alexander, G.J.; Williams, R. 1991: CMV reinfection/reactivation after liver transplantation Transplantation Proceedings 23(5): 2632-2633
Gugenheim, J.; Crafa, F.; Fabiani, P.; Militerno, G.; Goubaux, B.; Saint-Paul, M.C.; Ouzan, D.; Mouiel, J. 1992: Recurrence of virus B hepatitis after liver transplantation Gastroenterologie Clinique et Biologique 16(5): 430-433
Rambusch, E.G.; Nashan, B.; Tillmann, H.L.; Böker, K.H.; Schlitt, H.J.; Maschek, H.; Raab, R.; Manns, M.P. 1998: De novo hepatitis B infection after liver transplantation--evidence for the need of active hepatitis B vaccination of liver transplantation candidates Zeitschrift für Gastroenterologie 36(12): 1027-1035
Payen, J.L.; Izopet, J.; Barange, K.; Puel, J.; Selves, J.; Pascal, J.P. 1998: Hepatitis C virus reinfection after an intravenous drug injection Gastroenterologie Clinique et Biologique 22(4): 469-470
Karasu, Z.; Ozacar, T.; Akyildiz, M.; Demirbas, T.; Arikan, C.; Kobat, A.; Akarca, U.; Ersoz, G.; Gunsar, F.; Batur, Y.; Kilic, M.; Tokat, Y. 2004: Low-dose hepatitis B immune globulin and higher-dose lamivudine combination to prevent hepatitis B virus recurrence after liver transplantation Antiviral Therapy 9(6): 921-927
Suga, M. 1993: Clinical features of hepatitis C virus infection Hokkaido Journal of Medical Science 68(4): 450-455
Mulligan, D.C.; Goldstein, R.M.; Crippin, J.S.; Abouljoud, M.S.; Levy, M.F.; Husberg, B.S.; Gonwa, T.A.; Foster, B.R.; Tillery, G.W.; Klintmalm, G.B. 1995: Use of anti-hepatitis C virus seropositive organs in liver transplantation Transplantation Proceedings 27(1): 1204-1205
Ilan, Y.; Eid, A.; Tur-Kaspa, R. 1995: Long-term prevention of recurrent hepatitis B virus after liver transplantation Israel Journal of Medical Sciences 31(8): 469-473
Mueller, A.R.; Platz, K.P.; Christe, W.; Bechstein, W.O.; Blumhardt, G.; Neuhaus, P. 1994: Severe neurotoxicity after liver transplantation: association between FK 506 therapy and hepatitis C virus disease Transplantation Proceedings 26(6): 3131-3132